Colestid and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Colestid (colestipol hydrochloride), especially for people who are female, 60+ old, also take Norco, and have Multiple myeloma.

The study is created by eHealthMe based on reports of 2,172 people who have side effects when taking Colestid from the FDA, and is updated regularly.

What is Colestid?

Colestid has active ingredients of colestipol hydrochloride. It is often used in irritable bowel syndrome. eHealthMe is studying from 2,233 Colestid users. Check the latest studies of Colestid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 09, 2026

2,172 people reported to have side effects when taking Colestid.
Among them, 43 people (1.98%) died.

Among these 43 people:

What is the gender of people who died when taking Colestid? *

female: 67.5 %
male: 32.5 %

What is the age of people who died when taking Colestid? *

What are other drugs people take besides Colestid? *

What are other side effects people have before they died? *

Stress And Anxiety: 12 people, 27.91%
Dyspnea (difficult or laboured breathing): 8 people, 18.60%
Anaemia (lack of blood): 8 people, 18.60%
Fainting (loss of consciousness and postural tone): 8 people, 18.60%
Infection: 8 people, 18.60%
Pain: 8 people, 18.60%
Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body): 7 people, 16.28%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 7 people, 16.28%
Chondrocalcinosis (crystal deposition disease): 7 people, 16.28%
Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 16.28%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 11 people, 25.58%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 9 people, 20.93%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 1 person, 2.33%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 2.33%
Amyloidosis Senile (common form of amyloidosis in very old people, usually mild and limited to the heart): 1 person, 2.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.33%
Bladder Cancer: 1 person, 2.33%
Breast Cancer Female: 1 person, 2.33%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 2.33%
Chronic Respiratory Failure: 1 person, 2.33%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Colestid:

Colestid (2,233 reports)

Expand to all the drugs that have ingredients of colestipol hydrochloride:

Death and drugs with ingredients of colestipol hydrochloride (118 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Colestid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,107 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on colestipol hydrochloride (the active ingredients of Colestid) and Colestid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.